Evidence map›Paper›PMID 29332219›Full record

ArticlePediatric nephrology (Berlin, Germany)2018

Desensitisation strategies in high-risk children before kidney transplantation.

Ankit Sharma, Anne M Durkan

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ankit SharmaCentre for Kidney Research, The Children's Hospital at Westmead, Sydney, NSW, 2145, Australia.
Anne M DurkanCentre for Kidney Research, The Children's Hospital at Westmead, Sydney, NSW, 2145, Australia. anne.durkan@health.nsw.gov.au.ORCID 0000-0002-5721-2114

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTransplantation is the preferred modality for renal replacement therapy in children. With increasing rates of re-transplantation within the paediatric population, there are more sensitised children on waiting lists. One issue with developing strategies to treat these children is the number of different definitions of sensitisation. and we would therefore recommend an immunological risk stratification approach.

methodsWe discuss methods of sensitisation prevention, assessment and management, including paired exchange programmes and desensitisation protocols.

resultsThere are limited published evidence-based data for desensitisation in adults and none in children; thus, we present information on the available therapies currently in use. DISCUSSION: Further research is required to investigate strategies which prevent sensitisation in children, including the healthcare utility of incorporating epitope-based matching into organ allocation algorithms. Controlled studies are also needed to establish the most appropriate desensitisation regimen(s).

Indexed as

AllograftsChildDesensitization, ImmunologicDonor SelectionGraft RejectionGraft SurvivalHistocompatibility TestingHLA AntigensHumansKidneyKidney Failure, ChronicKidney TransplantationPreoperative CareReoperationRisk AssessmentHLA AntigensAntibody mediated rejectionDesensitisationImmunoglobulinKidneyPlasmapheresisRituximabTransplant

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.